CMC Session: Continuing Discussion: Statistical Considerations for Continuous Manufacturing Processes
*Celia N. Cruz, CDER/Office of Pharmaceutical Science/IO Keywords: This is a continuation of the session from last year, extending discussion around the evolving topic of statistical considerations for continuous manufacturing. In addition to presenting an update on the current FDA perspective on this topic, the session will introduce perspective and experience from a non-pharmaceutical industry in which continuous manufacturing processes have been successfully used for many years.
|
Key Dates
-
June 3, 2014 - September 7, 2015
Online Registration -
June 3, 2015 - August 15, 2015
Housing -
July 31 - August 17, 2015
Invited Abstract Editing -
August 10, 2015
Short Course materials due from Instructors -
August 26, 2015
Advanced Registration Deadline -
September 7, 2015
Cancellation Deadline -
September 16 - 18, 2015
Marriott Wardman Park, Washington, DC